Literature DB >> 19545284

Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.

Christine Damm-Welk1, Wolfram Klapper, Ilske Oschlies, Stefan Gesk, Silja Röttgers, Jutta Bradtke, Reiner Siebert, Alfred Reiter, Willi Woessmann.   

Abstract

Anaplastic large cell lymphomas (ALCL) in children express anaplastic lymphoma kinase (ALK) fusion genes, most commonly NPM1-ALK. The distribution of X-ALK among 66 childhood ALCLs was analysed. One ALCL was ALK-negative. Reverse transcription polymerase chain reaction detected NPM1-ALK in 58 tumours, all showing nuclear and cytoplasmic ALK staining. The remaining seven ALCL stained for ALK in the cytoplasm only: two expressed TPM3-ALK, one ATIC-ALK, one MYH9-ALK; three no TPM3-, TFG-, ATIC-, CLTC- or MYH9-ALK. Almost 90% of paediatric ALK-positive ALCLs express NPM1-ALK. There was complete concordance between ALK staining pattern and the presence of a typical/variant ALK fusion partner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545284     DOI: 10.1111/j.1365-2141.2009.07754.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

Review 1.  ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.

Authors:  Ilske Oschlies; Jasmin Lisfeld; Laurence Lamant; Atsuko Nakazawa; Emanuele S G d'Amore; Ulrika Hansson; Konnie Hebeda; Ingrid Simonitsch-Klupp; Jadwiga Maldyk; Leonhard Müllauer; Marianne Tinguely; Markus Stücker; Marie-Cecile Ledeley; Reiner Siebert; Alfred Reiter; Laurence Brugières; Wolfram Klapper; Wilhelm Woessmann
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Identification of gene fusions from human lung cancer mass spectrometry data.

Authors:  Han Sun; Xiaobin Xing; Jing Li; Fengli Zhou; Yunqin Chen; Ying He; Wei Li; Guangwu Wei; Xiao Chang; Jia Jia; Yixue Li; Lu Xie
Journal:  BMC Genomics       Date:  2013-12-09       Impact factor: 3.969

Review 3.  [Malignant lymphomas in children and adolescents. Practical knowledge for diagnosis].

Authors:  I Oschlies; W Klapper
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

4.  Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.

Authors:  V K Singh; S Werner; H Hackstein; V Lennerz; A Reiter; T Wölfel; C Damm-Welk; W Woessmann
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

5.  Genetics of anaplastic large cell lymphoma.

Authors:  Yu Zeng; Andrew L Feldman
Journal:  Leuk Lymphoma       Date:  2015-07-21

Review 6.  Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Rodney R Miles; Rikin K Shah; J Kimble Frazer
Journal:  Br J Haematol       Date:  2016-03-11       Impact factor: 6.998

Review 7.  Genetic Landscape and Classification of Peripheral T Cell Lymphomas.

Authors:  Rosalind F Sandell; Rebecca L Boddicker; Andrew L Feldman
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

8.  Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Dmitriy Abramov; Ilske Oschlies; Martin Zimmermann; Dmitriy Konovalov; Christine Damm-Welk; Wilhelm Wössmann; Wolfram Klapper
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 9.  Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management.

Authors:  Nabila Bennani-Baiti; Stephen Ansell; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2015-12-11       Impact factor: 2.929

10.  Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.

Authors:  Leandro Cerchietti; Christine Damm-Welk; Inga Vater; Wolfram Klapper; Lana Harder; Christiane Pott; Shao Ning Yang; Alfred Reiter; Reiner Siebert; Ari Melnick; Willi Woessmann
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.